Literature DB >> 8749882

Prodromal symptoms and relapse prevention in schizophrenia.

M I Herz1, J S Lamberti.   

Abstract

The value of monitoring for prodromal symptoms in patients with schizophrenia has been questioned by some investigators who point out that their positive predictive value, sensitivity, and specificity can be low in relation to relapse. This article focuses on methodological and conceptual issues which should be considered in evaluating the usefulness of prodromal symptoms and behaviors as part of the relapse process. The article presents the following conclusions: Many relapses are preceded by the appearance of prodromal symptoms and behaviors which may last from a few days to a few weeks or more. The presence of prodromal symptoms often does not predict impending relapse since the probability of progression to relapse depends on the complex interaction of many personal and environmental factors including the availability of prompt and effective psychiatric intervention. Finally, studies have shown that monitoring for prodromal symptoms and early intervention when they emerge is effective in reducing the likelihood of relapse in individuals with schizophrenia.

Entities:  

Mesh:

Year:  1995        PMID: 8749882     DOI: 10.1093/schbul/21.4.541

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

1.  Psychiatric disorder and unmet service needs among welfare clients in a representative payee program.

Authors:  Jovier D Evans; Dustin E Wright; Soren Svanum; Gary R Bond
Journal:  Community Ment Health J       Date:  2004-12

2.  Role of polygenic and environmental factors in the co-occurrence of depression and psychosis symptoms: a network analysis.

Authors:  Liliana Garcia-Mondragon; Deniz Konac; Joanne B Newbury; Katherine S Young; Alex Ing; Anna E Fürtjes; Edward D Barker
Journal:  Transl Psychiatry       Date:  2022-06-22       Impact factor: 7.989

3.  Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.

Authors:  Bernadette A Cullen; Katrina Rodriguez; William W Eaton; Ramin Mojtabai; Tara Von Mach; Michele L Ybarra
Journal:  Psychiatry Res       Date:  2020-07-29       Impact factor: 3.222

4.  Realising stratified psychiatry using multidimensional signatures and trajectories.

Authors:  Dan W Joyce; Angie A Kehagia; Derek K Tracy; Jessica Proctor; Sukhwinder S Shergill
Journal:  J Transl Med       Date:  2017-01-18       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.